An analysis of a first-in-human study of NEXI-001 donor-derived antigen-specific CD8+T-cell treatment of relapsed AML after allogeneic hematopoietic cell transplantation (HCT)
JOURNAL OF CLINICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要